glp 1 non alcoholic fatty liver GLP-1 Receptor Agonist and Non-Alcoholic Disease SGLT-2 inhibitors and GLP-1 receptor
Description
Stopping suddenly: Unlike some medications, dapagliflozin does not require gradual tapering it can be stopped abruptly

The trials differed significantly in their design, including baseline patient characteristics (e.g., the REWIND trial included a majority of patients for primary prevention, whereas others focused on high-risk secondary prevention populations), follow-up duration, and specific drug properties, all of which likely contribute to the variable magnitude of benefit observed [63]

Variability arises from clinician judgment, pharmacy availability, and program terms rather than fixed timelines or guarantees

A further limitation was the studys relatively short duration (26 weeks) with liraglutide 1.8 mg

You also exerciseda lot (and maybe pulled a few muscles here and there in the name of health and fitness)

Nearly half of hormone therapy users achieved at least 20% total body weight loss versus only 18% in the monotherapy group
